Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  70714-01 P450 Link Between Hormonal and Chemical Carcinogenesis End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
70714-01 P450 Link Between Hormonal and Chemical Carcinogenesis



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 70714-01 P450 LINK BETWEEN HORMONAL AND CHEMICAL CARCINOGENESIS

  3. Project Focus: EXPOSURE ASSESSMENT

  4. Description: Studies of the role of estrogens (Es) in the etiology of breast cancer have focused on their receptor- mediatedactions as mitogens. However, such actions of Es can not fully explain either laboratory or epidemiological data.However, Es can undergo P450- mediated metabolic activation to generate electrophilic species which are knowninitiators of carcinogenesis. This concept has evolved from studies of the biogenesis and characteristics of 2- and 4- hydroxylated catechol metabolites of Es (2- and 4-OH-CEs) which may damage DNA via oxygen free radicals generatedby redox cycling of CEs or by causing depurinating adducts via their quinone metabolites. The mechanisms involved areanalogous to those by which xenobiotic procarcinogens undergo P450-mediated metabolic activation to proximalcarcinogens. The overall hypothesis states that 2- and 4-OH- CEs generated in the gland, in particular 4-OH-CEs, are important determinants of P450- mediated Es role in carcinogenesis, in particular, in the early initiating stages of thedisease. According to this postulate P450s which can generate CEs and their quinone derivatives and support redoxcycling of CEs provide an interface between chemical and hormonal carcinogenesis, since these forms of P450 Es areinducible by xenobiotics. The relevance of this postulate to breast cancer is supported by recent cytochemical findingsthat all of the forms of P450 required for such a mechanism are expressed in ductal epithelial cells in the normal humanbreast. The forms of P450 identified include P45O1A1 and 3A4 which can catalyze formation of 2- OH-CEs and redoxcycling of CEs, as well as recently identified P4501B1 which, in its dioxin-inducible form in MCF-7 cells, is an E-4- hydroxylase. This is the first P450 known which generates 4- OH-CEs preferentially, the class of CEs which theinvestigator proposes may play a special role in carcinogenesis since they are potent long acting Es and may be lessreadily inactivated than 2-OH-CEs. The specific goal of proposed experiments is to determine if the constitutive form ofP4501B1 expressed in human mammary gland, like that induced by ioxins in cultured cells, is an E-4-hydroxylase andthe extent to which its sequence conforms to that induced by dioxin. Probes for screening cDNA libraries from humanbreast parenchyma will be obtained by polymerase chain reaction applied to reverse transcripts (RT/PCR) to RNAprepared from the same tissue and using asymmetrical primers based on the sequences used to identified P4501B1 inhuman breast by in situ hybridization.

  5. References:

  6. Category: METHODS

  7. Subcategory: BASIC RESEARCH

  8. Keywords for Experimental System/Species: HUMAN, LABORATORY STUDY, IN VITRO

  9. Keywords for Experimental Endpoints: CARCINOGENESIS, HORMONAL MEASURES, XENOBIOTIC METABOLISM, CYTOCHROME P450

  10. Chemical Agents: DIOXIN

  11. Performing Institution: PENNSYLVANIA STATE UNIV HERSHEY MED CTR

  12. Contact: CONTRACT PERSON: ELAINE C. LEE; BUILDING 31; 11A21; NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301-496-5515; LEEE@OD.NCI.NIH.GOV


 

 
Begin Site Footer